Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with neisseria meningitidis opacity protein: Influence on endotoxic and adjuvant activity

Clinical and Vaccine Immunology

Volumn 17, Issue 4, 2010, Pages 487-495

  Arenas, Jesús ^a,b   Dijken, Harry Van ^b   Kuipers, Betsy ^b   Hamstra, Hendrik Jan ^b   Tommassen, Jan ^a   Der Ley, Peter Van ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM PHOSPHATE; BACTERIAL PROTEIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOSOME; PROTEIN LPXL1; PROTEIN OPAJ; PROTEIN PAGL; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; BACTERICIDAL ACTIVITY; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG ENDOTOXICITY; MACROPHAGE; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEOLIPOSOME;

ACYLTRANSFERASES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BORDETELLA BRONCHISEPTICA; CELL LINE; FEMALE; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIPOSOMES; MACROPHAGES; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS;

EID: 77950640286     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00423-09     Document Type: Article

References (48)

1. Arenas, J., A. Abel, S. Sánchez, J. Marzoa, S. Berrón, P. van der Ley, M. T. Criado, and C. M. Ferreiros. 2008. A cross-reactive neisserial antigen encoded by the NMB0035 locus shows high sequence conservation but variable surface accessibility. J. Med. Microbiol. 57:80-87.
2. Arigita, C., W. Jiskoot, J. Westdijk, C. van Ingen, W. E. Hennink, D. J. A. Crommelin, and G. F. A. Kersten. 2004. Stability of mono-and trivalent meningococcal outer membrane vesicle vaccines. Vaccine 22:629-642.
3. Arigita, C., T. Luijkx, W. Jiskoot, M. Poelen, W. E. Hennink, D. J. A. Crommelin, P. van der Ley, C. van Els, and G. F. A. Kersten. 2005. Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives. Vaccine 23:5091-5098.
4. Badiee, A., M. R. Jaafari, A. Samiei, D. Soroush, and A. Khamesipour. 2008. Co-encapsulation of CpG ODN with rLmSTI1 in liposome enhances immune response and protection in immunized BALB/c mice against leishman-iasis. Clin. Vaccine Immunol. 15:668-674.
5. Bowden, R. A., A. Cloeckaert, M. S. Zygmunt, S. Bernard, and G. Dubray. 1995. Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry. Infect. Immun. 63:3945-3952.
6. Brandenburg, K., B. Lindner, A. Schromm, M. H. J. Koch, J. Bauer, A. Merkli, C. Zbaeren, J. G. Davies, and U. Seydel. 2000. Physicochemical characteristics of triacyl lipid A partial structure OM-174 in relation to biological activity. Eur. J. Biochem. 267:3370-3377.
7. Braun, V., M. Braun, and H. Killmann. 2000. Iron transport in Escherichia coli. Crystal structure of FhuA, an outer membrane iron and antibiotic transporter. Adv. Exp. Med. Biol. 485:33-43.
8. Chhibber, S., S. Wadhwa, and V. Yadav. 2004. Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia. Jpn. J. Infect. Dis. 57:150-155.
9. de Jonge, M. I., M. P. Bos, H. J. Hamstra, W. Jiskoot, P. van Ulsen, J. Tommassen, L. van Alphen, and P. van der Ley. 2002. Conformational analysis of opacity proteins from Neisseria meningitidis. Eur. J. Biochem. 269:5215-5223.
10. de Jonge, M. I., H. J. Hamstra, W. Jiskoot, P. Roholl, N. A. Williams, J. Dankert, L. van Alphen, and P. van der Ley. 2004. Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins. Vaccine 22:4021-4028.
11. Delgado, M., D. Yero, O. Niebla, S. Gonzalez, Y. Climent, Y. Perez, K. Cobas, E. Caballero, D. Garcia, and R. Pajon. 2007. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate. Vaccine 25:8420-8431.
12. Desiderio, J. V., and S. G. Campbell. 1985. Immunization against experimental murine salmonellosis with liposome-associated O-antigen. Infect. Immun. 48:658-663.
13. de Vries, J. J. C., L. Bungener, W. ter Veer, L. van Alphen, P. van der Ley, J. Wilschut, and A. Huckriede. 2009. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity. Vaccine 27:947-955.
14. Dijkstra, J., J. W. Larrick, J. L. Ryan, and F. C. Szoka. 1988. Incorporation of LPS in liposomes diminishes its ability to induce tumoricidal activity and tumor necrosis factor secretion in murine macrophages. J. Leukoc. Biol. 43:436-444.
15. Dijkstra, J., J. W. Mellors, J. L. Ryan, and F. C. Szoka. 1987. Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J. Immunol. 138:2663-2670.
16. Ey, P. L., G. J. Russell-Jones, and C. R. Jenkin. 1980. Isotypes of mouse IgG-1. Evidence for 'non-complement-fixing' IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement. Mol. Immunol. 17:699-710.
17. Finne, J., M. Leinonen, and P. H. Mäkelä. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet ii:355-357.
18. Fisseha, M., P. Chen, B. Brandt, T. Kijek, E. Moran, and W. Zollinger. 2005. Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infect. Immun. 73:4070-4080.
19. Fomsgaard, A., M. A. Freudenberg, and C. Galanos. 1990. Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J. Clin. Microbiol. 28:2627-2631.
20. Geurtsen, J., L. Steeghs, H. J. Hamstra, J. Ten Hove, A. de Haan, B. Kuipers, J. Tommassen, and P. van der Ley. 2006. Expression of the lipopolysaccha-ride-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis. Infect. Immun. 74:5574-5585.
21. Geurtsen, J., R. J. Vandebriel, E. R. Gremmer, B. Kuipers, J. Tommassen, and P. van der Ley. 2007. Consequences of the expression of lipopolysac-charide- modifying enzymes for the efficacy and reactogenicity of whole-cell pertussis vaccines. Microbes Infect. 9:1096-1103.
22. Guzman, C. A., G. Molinari, M. W. Fountain, M. Rohde, K. N. Timmis, and M. J. Walker. 1993. Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hem-agglutinin and pertussis toxoid. Infect. Immun. 61:573-579.
23. Humphries, H. E., J. N. Williams, R. Blackstone, K. A. Jolley, H. M. Yuen, M. Christodoulides, and J. E. Heckels. 2006. Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis. Vaccine 24:36-44.
24. Jain, V., R. Sahu, S. Misra-Bhattacharya, S. P. Vyas, and D. Kohli. 2008. Enhancement of T-helper type I immune responses against hepatitis B surface antigen by LPS derivatives adjuvanted liposomes delivery system. J. Drug Target 16:706-715.
25. Luijkx, T. A., H. H. van Dijken, H. J. Hamstra, B. Kuipers, P. van der Ley, L. van Alphen, and G. van den Dobbelsteen. 2003. Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation form. Infect. Immun. 71:6367-6371.
26. McCluskie, M. J., R. D. Weeratna, and H. L. Davis. 2001. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants. Vaccine 19: 2657-2660.
27. Mirlashari, M. R., and T. Lyberg. 2003. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis. Med. Sci. Monit. 9:BR316-BR324.
28. Nikaido, H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593-656.
29. Oster, P., D. Lennon, J. O'Hallahan, K. Mulholland, S. Reid, and D. Martin. 2005. MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 23:2191-2196.
30. Palsson-McDermott, E. M., and L. A. O'Neill. 2004. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113:153-162.
31. Patel, G. B., H. Zhou, A. Ponce, and W. Chen. 2007. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adju-vanted vaccines. Vaccine 25:8622-8636.
32. Petrov, A. B., B. F. Semenov, Y. P. Vartanyan, M. M. Zakirov, V. P. Torchi-lin, V. S. Trubetskoy, N. V. Koshkina, V. L. L'Vov, I. K. Verner, I. V. Lopyrev, and B. A. Dmitriev. 1992. Toxicity and immunogenicity of Neisseria menin-gitidis lipopolysaccharide incorporated into liposomes. Infect. Immun. 60: 3897-3903.
33. Richards, R. L., M. Rao, N. M. Wassef, G. M. Glenn, S. W. Rothwell, and C. R. Alving. 1998. Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen. Infect. Immun. 66:2859-2865.
34. Rouser, G., S. Fkeischer, and A. Yamamoto. 1970. Two dimensional thin layer chromatographic separation of polar lipids and determination of phos-pholipids by phosphorous analysis of spots. Lipids 5:494-496.
35. Singh, M., A. Chakrapani, and D. O'Hagan. 2007. Nanoparticles and micro-particles as vaccine-delivery systems. Expert Rev. Vaccines 6:797-808.
36. Steeghs, L., M. Berns, J. Ten Hove, A. de Jong, P. Roholl, L. van Alphen, J. Tommassen, and P. van der Ley. 2002. Expression of foreign LpxA acyl-transferases in Neisseria meningitidis results in modified lipid A with reduced toxicity and retained adjuvant activity. Cell. Microbiol. 4:599-611.
37. Steeghs, L., H. de Cock, E. Evers, B. Zomer, J. Tommassen, and P. van der Ley. 2001. Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant. EMBO J. 20:6937-6945.
38. Steeghs, L., R. den Hartog, A. den Boer, B. Zomer, P. Roholl, and P. van der Ley. 1998. Meningitis bacterium is viable without endotoxin. Nature 392: 449-450.
39. Steeghs, L., B. Kuipers, H. J. Hamstra, G. Kersten, L. van Alphen, and P. van der Ley. 1999. Immunogenicity of outer membrane proteins in a lipopo-lysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response. Infect. Immun. 67:4988-4993.
40. Takada, H., and S. Kotani. 1989. Structural requirements of lipid A for endotoxicity and other biological activities. Crit. Rev. Microbiol. 16:477-523.
41. Toropainen, M., L. Saarinen, P. van der Ley, B. Kuipers, and H. Kayhty. 2001. Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model. Microb. Pathog. 30:139-148.
42. Trinchieri, G., and A. Sher. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7:179-190.
43. van der Ley, P., and L. Steeghs. 2003. Lessons from an LPS-deficient Neis-seria meningitidis mutant. J. Endotoxin Res. 9:124-128.
44. van der Ley, P., L. Steeghs, H. J. Hamstra, J. Ten Hove, B. Zomer, and L. van Alphen. 2001. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect. Immun. 69:5981-5990.
45. Venkatesan, N., and S. P. Vyas. 2000. Polysaccharide coated liposomes for oral immunization\development and characterization. Int. J. Pharm. 203: 169-177.
46. Weeratna, R. D., C. L. Brazolot Millan, M. J. McCluskie, and H. L. Davis. 2001. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. FEMS Immunol. Med. Microbiol. 32: 65-71.
47. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharide extraction with phenol-water and further applications of the procedure. Methods Car-bohydr. Chem. 5:83-91.
48. Zhu, D., V. Barniak, Y. Zhang, B. Green, and G. Zlotnick. 2006. Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis. Vaccine 24:5420-5425.